Accolade

Accolade CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Accolade (ACCD) as of Nov 20, 2026 is -4.33 %. In the previous year, Cash Return on Invested Capital (CROIC) was -6.33 % — a change of -31.58% (higher).

CROIC

-4.33 %

YoY

-31.58%

Last updated:

Cash Return on Invested Capital (CROIC) of Accolade is 2024 -4.33 % . Cash Return on Invested Capital (CROIC) of Accolade was 2023 -6.33 % . It decreases by -31.58% higher compared to the previous year.

The Accolade CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
27.91 USD
Jan 1, 2019
9.30 USD
Jan 1, 2020
1,405.24 USD
Jan 1, 2021
-7.06 USD
Jan 1, 2022
-5.80 USD
Jan 1, 2023
-6.33 USD
Jan 1, 2024
-4.33 USD
The Accolade CROIC history
YEARCROICYoY
-4.33 %-31.58%
-6.33 %+9.19%
-5.80 %-17.84%
-7.06 %-100.50%
1,405.24 %+15,007.13%
9.30 %-66.67%
27.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accolade Stock analysis

What does Accolade do? Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accolade stock

Cash Return on Invested Capital (CROIC) of Accolade is -4.33 % in 2024.

Cash Return on Invested Capital (CROIC) of Accolade changed from -6.33 % to -4.33 %, representing a -31.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Accolade since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Accolade with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Accolade

All Key Metrics — Accolade